Siponimod is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS). This medication is designed to reduce the frequency of relapses or flare-ups of MS by modulating the immune system. It is thought to work by helping to reduce inflammation in the central nervous system. Siponimod may also help to slow down the progression of physical disability in people with MS.
Siponimod is a medication used to treat relapsing forms of multiple sclerosis (MS) in adults [1]. Here's a breakdown of its key points:
- Conditions it treats: Relapsing-remitting MS, clinically isolated syndrome (CIS, an initial episode of MS symptoms), and active secondary progressive MS (a later stage with worsening symptoms) [1].
- How it works: Siponimod is a sphingosine-1-phosphate (S1P) receptor modulator [2]. It's thought to work by affecting certain immune system cells (lymphocytes) that can damage nerves in MS [2, 5]. By affecting these cells, Siponimod helps reduce inflammation and slow disease progression [5].
- Dosage: It comes in tablet form, typically taken once a day [4].
Important things to know:
- Siponimod is not a cure for MS, but it can help manage relapses and slow disability [5].
- It's important to discuss the use of Siponimod with a healthcare professional, as it can have side effects and may interact with other medications [1].
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L04 Immunosuppressants
L04A - Immunosuppressants
L04AA Selective immunosuppressants
ATC Code
External Links
Siponimod